- Home
- INTZ vs RVPH Comparison
INTZ vs RVPH Comparison
Compare INTZ & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTZ
- RVPH
- Stock Information
- Founded
- INTZ 1983
- RVPH 2006
- Country
- INTZ United States
- RVPH United States
- Employees
- INTZ N/A
- RVPH N/A
- Industry
- INTZ Computer Communications Equipment
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- INTZ Telecommunications
- RVPH Health Care
- Exchange
- INTZ Nasdaq
- RVPH Nasdaq
- Market Cap
- INTZ 33.2M
- RVPH 30.1M
- IPO Year
- INTZ 2020
- RVPH N/A
- Fundamental
- Price
- INTZ $1.69
- RVPH $0.40
- Analyst Decision
- INTZ Buy
- RVPH Strong Buy
- Analyst Count
- INTZ 2
- RVPH 5
- Target Price
- INTZ $6.50
- RVPH $5.20
- AVG Volume (30 Days)
- INTZ 145.7K
- RVPH 1.2M
- Earning Date
- INTZ 10-08-2025
- RVPH 11-13-2025
- Dividend Yield
- INTZ N/A
- RVPH N/A
- EPS Growth
- INTZ N/A
- RVPH N/A
- EPS
- INTZ N/A
- RVPH N/A
- Revenue
- INTZ $6,828,000.00
- RVPH N/A
- Revenue This Year
- INTZ $36.75
- RVPH N/A
- Revenue Next Year
- INTZ $30.90
- RVPH N/A
- P/E Ratio
- INTZ N/A
- RVPH N/A
- Revenue Growth
- INTZ 25.86
- RVPH N/A
- 52 Week Low
- INTZ $0.35
- RVPH $0.30
- 52 Week High
- INTZ $7.34
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- INTZ 50.68
- RVPH 32.52
- Support Level
- INTZ N/A
- RVPH $0.50
- Resistance Level
- INTZ $1.74
- RVPH $0.47
- Average True Range (ATR)
- INTZ 0.08
- RVPH 0.03
- MACD
- INTZ -0.06
- RVPH -0.01
- Stochastic Oscillator
- INTZ 90.37
- RVPH 2.29
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.